Skip to content

A Prospective Analysis of Biofilm in Urinary Catheters Study

A Prospective Anaylsis of Biofilm in Urinary Catheters Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01987336
Enrollment
9
Registered
2013-11-19
Start date
2013-03-31
Completion date
2015-12-31
Last updated
2015-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence

Keywords

Standard Foley Catheter

Brief summary

To analyze biofilm obtained from at least 10 Subjects who have an indwelling catheter. A 30cc urine sample would also be collected from the same subject, and analyzed.

Detailed description

After obtaining informed consent, concurrent with the changing of the Foley catheter in the clinic, would be obtaining a 30 cc. sample of urine which would also be fast frozen and stored in a -81 degree freezer until shipped to the Venter clinic on dry ice.

Interventions

None listed

Sponsors

Southwest Regional Wound Care Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Subject must be 18 years of age. 2. Subject is attending weekly office visits at SW Wound Care Center as an out- patient. 3. Subject must have an indwelling Foley catheter. 4. Subject is informed about the trial, understands its nature of the study and provides written informed consent prior to study enrollment. 5. Subject is willing and able to comply with all specified care and visit requirements.

Exclusion criteria

1\. Subject refuses to participate in the study. 2. Subject is expected to be non-compliant. 3. Subject is a resident in a nursing home, or institutionalized. 4. Subject is pregnant. 5. Subject has a Legally Authorized Representative \-

Design outcomes

Primary

MeasureTime frameDescription
To analyze biofilm obtained from at least 10 Subjects who have an indwelling catheter.Over a period of 20 weeksthe proteomics, metabolomics and metagenomics (omics) data will be analyzed and integrated in order to understand the microbial population dynamics and the interactions with the human subject host responses which may include antibacterial defenses, local inflammation, immune tolerance towards bacteria

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026